Archive Newsletter

1. 07.11.26 -- Cell & Gene Newsletter - Best Of June 7/11/2026
   07/11/26 Cell & Gene Newsletter
2. 07.10.26 -- Managing Supply Disruptions In ATIMP Clinical Trials 7/10/2026
   07/10/26
3. 07.09.26 -- From Clone To Commercial: Redefining Cell Therapy Workflows 7/9/2026

   07/09/26 Cell & Gene Newsletter

4. 07.09.26 -- Applying Contamination Control By Design: A Practical Guide For CDMOs 7/9/2026
   07/09/26 Cell & Gene Newsletter
5. 07.08.26 -- Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers 7/8/2026
   07/08/26 Cell & Gene Newsletter
6. 07.07.26 -- STREAM Edition: Targeting Tau In Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D. 7/7/2026

   07/07/26 Cell & Gene Newsletter

7. 07.07.26 -- AI Has Arrived In Biotech CMC Amid Patchwork Governance 7/7/2026
   07/07/26 Cell & Gene Newsletter
8. 07.06.26 -- In An Era Of Overcapacity, Should Companies Rent, Lease, Or Build Their Manufacturing Future? 7/6/2026
   07/06/26 Cell & Gene Newsletter
9. 07.03.26 -- Hormuz Deal Brings Cautious Relief To Pharma Packaging Supply Chains 7/3/2026
   07/03/26 Cell & Gene Newsletter
10. 07.02.26 -- New Podcast Episodes: A Midyear Look At Life Sciences, Derisking CNS Drug Development, In Vivo Gene Editing 7/2/2026
    07/02/26 Cell & Gene Newsletter